Physician profile
Stephen Sacks
NPI 1073543369
$3,486.46
in general payments reported to CMS, 2019-2025
29 companies · $690 in 2025
The $690 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $495 · 2020: $128 · 2021: $440 · 2022: $536 · 2023: $568 · 2024: $630 · 2025: $690.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,888.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,887.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $623.88 | 2019-2025 | |
| Abbvie INC. | $538.46 | 2021-2025 | Botox |
| Janssen Biotech, INC. | $378.21 | 2019-2025 | Erleada |
| Dendreon Pharmaceuticals LLC | $291.53 | 2019-2025 | Provenge |
| Bayer Healthcare Pharmaceuticals INC. | $188.86 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $136.10 | 2021-2025 | Keytruda, Welireg |
| Telix Pharmaceuticals | $118.36 | 2024-2025 | Illuccix |
| Blue Earth Diagnostics | $114.25 | 2021-2024 | |
| Ferring Pharmaceuticals INC. | $107.02 | 2024-2025 | Adstiladrin |
| Myovant Sciences INC. | $105.78 | 2021-2022 | |
| Dornier Medtech America, INC | $102.06 | 2025 | Dornier Medtech |
| Profound Medical Corp. | $88.19 | 2023 | Tulsa-Pro |
| Boston Scientific Corporation | $86.59 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $84.91 | 2023-2025 | Orgovyx, Gemtesa |
| Progenics Pharmaceuticals, INC. | $74.20 | 2022-2024 | Pylarify |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $64.87 | 2024-2025 | |
| Astrazeneca Pharmaceuticals Lp | $54.93 | 2021-2023 | Lynparza |
| Immunitybio, INC. | $45.30 | 2025 | |
| Laborie Medical Technologies Corp. | $43.06 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Myriad Genetic Laboratories, INC. | $30.45 | 2021-2022 | |
| Amgen INC. | $28.80 | 2019 | |
| Teleflex LLC | $28.45 | 2021 | |
| Abc Home Medical Supply, INC. | $23.76 | 2025 | |
| Axonics, INC. | $22.39 | 2022 | |
| Karl Storz Endoscopy-America | $22.34 | 2019 | |
| Astellas Pharma US INC | $21.70 | 2021 | |
| Tolmar, INC. | $21.64 | 2023 | |
| Tolmar Pharmaceuticals, INC. | $20.34 | 2020 | |
| Allergan, INC. | $20.03 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Sacks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.